Drugs.com - Pharma Industry News

Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials

THURSDAY, June 12, 2025 -- For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent on average, which is lower than the percentages reported from clinical trials, according to a...

Jun 12, 2025 - 20:20
 0
Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials
THURSDAY, June 12, 2025 -- For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent on average, which is lower than the percentages reported from clinical trials, according to a...
Read More

Tags:

Previous Article

Shorter Leukocyte Telomere Length Linked to Higher Incidence of Age-Related Brai...

Next Article

Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance

Related Posts

Ubrogepant During Prodromal Phase of Migraine Eases Symptoms

Ubrogepant During Prodromal Phase of Migraine Eases Sym...

May 13, 2025  0

Many Heart Failure Patients Do Not See a Cardiologist Annually

Many Heart Failure Patients Do Not See a Cardiologist A...

May 22, 2025  0

Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance

Mitochondrial Genetics Key to Metastatic Melanoma Immun...

Jun 12, 2025  0